Guardant Health Retained Earnings Over Time
| GH Stock | USD 35.10 0.73 2.12% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Guardant Health Performance and Guardant Health Correlation. Guardant |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.7 | Quarterly Revenue Growth 0.339 | Return On Assets (0.16) | Return On Equity (6.09) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Retained Earnings Analysis
Compare Guardant Health and related stocks such as Illumina, Twist Bioscience Corp, and Natera Inc Retained Earnings Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ILMN | (6.7 M) | (68.7 M) | 82.5 M | 207.9 M | 561.2 M | 1 B | 1.5 B | 2.3 B | 3.1 B | 4.1 B | 4.7 B | 5.5 B | 1.1 B | (19 M) | (18.1 M) |
| TWST | (80.3 M) | (80.3 M) | (80.3 M) | (80.3 M) | (80.3 M) | (80.3 M) | (139.6 M) | (210.9 M) | (318.5 M) | (458.5 M) | (610.6 M) | (828.4 M) | (1 B) | (1.2 B) | (1.2 B) |
| NTRA | (137.5 M) | (137.5 M) | (137.5 M) | (174.7 M) | (179.8 M) | (250.1 M) | (345.8 M) | (482.2 M) | (574.5 M) | (699.2 M) | (929.3 M) | (1.4 B) | (1.9 B) | (2.4 B) | (2.3 B) |
| CDNA | (156.6 M) | (156.6 M) | (156.6 M) | (160.2 M) | (159.4 M) | (173.1 M) | (212.6 M) | (268 M) | (311.8 M) | (333.8 M) | (352.5 M) | (383.2 M) | (460.4 M) | (678.3 M) | (644.4 M) |
| MYGN | (14.9 M) | (38.6 M) | (12.7 M) | 30.9 M | 2 M | (77 M) | (73.2 M) | (68.4 M) | 52.8 M | 25.6 M | (227 M) | (254.2 M) | (366.2 M) | (629.5 M) | (598 M) |
| CSTL | (51.1 M) | (51.1 M) | (51.1 M) | (51.1 M) | (51.1 M) | (51.1 M) | (51.1 M) | (51.1 M) | (57.5 M) | (52.2 M) | (62.5 M) | (93.8 M) | (160.9 M) | (218.4 M) | (207.5 M) |
| PSNL | (95.6 M) | (95.6 M) | (95.6 M) | (95.6 M) | (95.6 M) | (95.6 M) | (95.6 M) | (95.6 M) | (115.5 M) | (140.6 M) | (181.9 M) | (247.1 M) | (360.4 M) | (468.7 M) | (445.3 M) |
| A | 757 M | 5.5 B | 6.1 B | 6.5 B | 5.6 B | 6.1 B | (126 M) | (336 M) | (18 M) | 81 M | 348 M | 324 M | 782 M | 899.3 M | 854.3 M |
| TMO | 55.4 M | 6.7 B | 7.7 B | 8.8 B | 10.4 B | 12.1 B | 13.9 B | 15.9 B | 18.7 B | 22.1 B | 28.1 B | 35.4 B | 41.9 B | 47.4 B | 49.7 B |
| DHR | (111.3 M) | 13.1 B | 15.4 B | 18 B | 20.3 B | 21 B | 20.7 B | 22.8 B | 25.2 B | 24.2 B | 27.2 B | 32.8 B | 39.2 B | 41.1 B | 43.1 B |
| CRL | 156.1 M | (465.6 M) | (368.3 M) | (265.5 M) | (138.8 M) | 10.5 M | 165.3 M | 288.7 M | 42.1 M | 280.3 M | 625.4 M | 980.8 M | 1.4 B | 1.9 B | 2 B |
Guardant Health and related stocks such as Illumina, Twist Bioscience Corp, and Natera Inc Retained Earnings description
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.My Equities
My Current Equities and Potential Positions
Check out Guardant Health Performance and Guardant Health Correlation. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Guardant Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.